Table 3.

The post vaccine adverse effects after vaccination in male and female subjects.

	Female		Male
	Number (2,874)	%	Number (1,296)	%	P-value
Severity of the side effects
No side effects	227	7.9	210	16.2	0.001
Mild	1,262	43.9	615	47.5
Moderate	887	30.9	311	24.0
Severe	471	16.4	148	11.4
Critical	27	0.9	12	0.9
Duration of the side effects
didn't have	250	8.7	216	16.7	0.001
1 day	699	24.3	425	32.8
2 days	1,022	35.6	415	32.0
3 days	492	17.1	132	10.2
4 days	143	5.0	33	2.5
5 days	84	2.9	22	1.7
6 days	15	0.5	5	0.4
7 days	57	2.0	10	0.8
> 7 days	112	3.9	38	2.9
Local reactions, n (%)
Pain	2,490	86.6	945	72.9	0.001
Swelling	825	28.7	245	18.9	0.001
Swollen lymph nodes	112	3.9	30	2.3	0.009
Systemic reactions, n (%)
Headache	1,353	47.1	456	35.2	0.001
Fever	1,256	43.7	524	40.4	0.048
Chill	759	26.4	279	21.5	0.001
Palpitation	377	13.1	85	6.6	0.001
Joint pain	1,161	40.4	447	34.5	0.001
Muscle pain	1,590	55.3	598	46.1	0.001
Fatigue	1,971	68.6	741	57.2	0.001
Impaired concentration	605	21.1	225	17.4	0.006
Insomnia	602	20.9	230	17.7	0.017
Dizziness	904	31.5	272	21.0	0.001
Diarrhea	238	8.3	77	5.9	0.008
Abdominal pain	259	9.0	72	5.6	0.001
Chest pain	333	11.6	80	6.2	0.001
Breathlessness	234	8.1	68	5.2	0.001
Allergic reaction, n (%)
Rash	88	3.1	28	2.2	0.101
Itching	296	10.3	71	5.5	0.001
Swollen lips	64	2.2	16	1.2	0.031

Data are showed as number (percentage). Chi-square test was used to calculate the p-value for the difference between the male and female subjects after the first dose of either BNT162b2 or ChAdOx1.